Top Markets
Coin of the day
Invitae Corporation Invitae Corporation

Invitae Corporation

NVTA
Clasificación en acciones #35931
Invitae Corporation operates as a medical genetics enterprise, striving to... Invitae Corporation operates as a medical genetics enterprise, striving to integrate genetic insights into mainstream medical practice to enhance healthcare outcomes for individuals in the United States, Canada, and internationally. The company provides a comprehensive suite of offerings, including genetic testing for various clinical specializations such as hereditary cancer, cardiovascular health, neurological disorders, pediatric conditions, oncology, metabolic ailments, and rare diseases, alongside digital health tools and health data services. Its clientele spans individual patients, healthcare providers, biopharmaceutical firms, and other collaborators. Established in 2010 as Locus Development, Inc., the company officially became Invitae Corporation in 2012 and is headquartered in San Francisco, California.
Precio por acción
$0.016
Última sincronización: 2024-03-11
Capitalización bursátil
$3.27M
Cambio (1 día)
-5.33%
Cambio (1 año)
0.00%
País
US
Comercio Invitae Corporation (NVTA)

Categoría

Ratio P/S de Invitae Corporation (NVTA)
Ratio P/S al 2026 TTM: 0
Según los informes financieros más recientes y el precio de las acciones de Invitae Corporation, el ratio P/S actual (TTM) es 0. Al final de 2026, el ratio P/S era 0.
Historial del ratio P/S de Invitae Corporation desde 2026 hasta 2026
Ratio P/S al final de cada año
Año Ratio P/S Cambiar
Not enough data for the provided dates.
Ratio P/S de empresas similares o competidoras
Empresa Ratio P/S Diferencia del ratio P/S País
4.72 -
US
5.67 -
US
- -
CN
16.40 -
US
9.55 -
US